Advertisement

Topics

Acorda reports deaths in Parkinson's trial, shares plunge

09:08 EST 15 Nov 2017 | Reuters

(Reuters) - Acorda Therapeutics Inc said it halted enrolling patients in two late-stage safety studies of its Parkinson's disease drug following deaths, sending its shares tumbling more than 40 percent in premarket trading.

Original Article: Acorda reports deaths in Parkinson's trial, shares plunge

NEXT ARTICLE

More From BioPortfolio on "Acorda reports deaths in Parkinson's trial, shares plunge"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...